Mapping the diversity of chronic lymphocytic leukemia at single-cell resolution
Two patients with chronic lymphocytic leukemia (CLL) can face very different futures. One may live for decades without needing treatment, while another may develop rapidly progressing disease. In a new study from Karolinska Institutet, published in the journal Blood Neoplasia, researchers map what distinguishes the two patient groups.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
